ResMed Inc (RME.HA)
Hanover - Hanover Delayed price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous close | 199.60 |
| Open | 199.20 |
| Bid | 199.05 x N/A |
| Ask | 203.10 x N/A |
| Day's range | 199.20 - 199.20 |
| 52-week range | 127.55 - 215.20 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireResMed Announces Participation in the RBCCM Global Healthcare Conference
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Dr. Carlos Nunez, Chief Medical Officer, and Amy Wakeham, Chief Investor Relations Officer, will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, beginning at approximately 4:05 p.m. (Eastern Daylight Time) at the InterContinental New York Barclay, in New York, NY. More information about this event, including access to the live, audio-only webcast, may b
ZacksIntegra's (IART) Q1 Earnings Match Estimates, Margins Down
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
ZacksHere's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
© 2024 Yahoo. All rights reserved.